<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04025606</url>
  </required_header>
  <id_info>
    <org_study_id>2017/2424</org_study_id>
    <nct_id>NCT04025606</nct_id>
  </id_info>
  <brief_title>Paravertebral Block Versus Thoracic Epidural Analgesia</brief_title>
  <official_title>Paravertebral Block Versus Thoracic Epidural Analgesia in Patients Undergoing Video Assisted Lung Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Olavs Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Olavs Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Thoracic epidural analgesia (TEA) is the basic method of analgesia in patients undergoing
      pulmonary lobectomy. TEA is considered to be a safe and thoroughly investigated method of
      pain relief that rarely causes serious complications. However, blocking the nerves as they
      emerge from the spinal column (paravertebral block, PVB) may represent an alternative method
      with some potential benefits. In this study, TEA and PVB will be compared for patients
      undergoing pulmonary lobectomy by video assisted thoracoscopic surgery. The aim of the study
      is to test the hypothesis, that PVB is a time-saving procedure compared with TEA on the day
      of surgery and that PVB is as efficient in postoperative pain reduction as TEA.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 24, 2019</start_date>
  <completion_date type="Anticipated">May 2021</completion_date>
  <primary_completion_date type="Anticipated">May 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time in minutes total time at the operating ward</measure>
    <time_frame>1 hour</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain intensity during hospitalization: Numerical Rating Scale (NRS)</measure>
    <time_frame>Up to 12 months after surgery</time_frame>
    <description>using the Numerical Rating Scale (NRS) in predetermined time intervals after the operation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hospital length of stay in days</measure>
    <time_frame>until discharge from hospital (max 1 month)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Lung Cancer</condition>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Thoracic epidural analgesia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard thoracic epidurals preoperatively at the dag of surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Paravertebral block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Paravertebral block inserted at the end of the operation by the surgeons</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Thoracic epidural</intervention_name>
    <description>Standard thoracic epidural (needle inserted into the space between the covering of spinal cord and the cord itself) preoperatively. Standard thoracic epidural analgesia mixture (2 mg/ ml bupivacaine, 2 µg/ ml fentanyl and 2 µg/ ml adrenalin) with an infusion of 6-10 ml/hour until day 2 postoperatively. Thereafter reduction by 30 % every four hours.</description>
    <arm_group_label>Thoracic epidural analgesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Paravertebral block</intervention_name>
    <description>Paravertebral block containing 5 ml bupivacaine 5 mg/ ml (optionally 10 ml bupivacaine 2,5 mg/ ml). In addition per-oral painkillers (oxycodone and paracetamol) from the day of surgery.</description>
    <arm_group_label>Paravertebral block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients with lung cancer in stage 1 or 2 who are accepted for VATS-lobectomy

        Exclusion Criteria, preoperative:

        Patients who do not wish to participate

        Patients with:

          -  suspicion of ingrowth in the thoracic wall.

          -  marginal lung function.

          -  kidney failure.

          -  chronic pains and/ or daily use of opioids.

          -  cognitive, visual and / or linguistic dysfunction.

          -  allergies to drugs used in the paravertebral block or the thoracic epidural analgesia.

        Exclusion Criteria, Per- and postoperative

          -  conversion from VATS to thoractomy.

          -  unsuccessful admission of thoracic epidural analgesia

          -  unsuccessful admission of paravertebral block

          -  postoperative respiratory treatment

          -  postoperative delirium Patients who for various reasons are not able to self-report
             pain after surgery.

        Patients who wish to withdraw from the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexander Wahba, md phd</last_name>
    <role>Study Director</role>
    <affiliation>St. Olavs Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lars Erik Berg Krogstad, md</last_name>
    <phone>0047 95166543</phone>
    <email>larserkr@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>St Olavs Hospital</name>
      <address>
        <city>Trondheim</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lars Erik Berg Krogstad, md</last_name>
      <email>larserkr@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 12, 2019</study_first_submitted>
  <study_first_submitted_qc>July 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 19, 2019</study_first_posted>
  <last_update_submitted>June 4, 2020</last_update_submitted>
  <last_update_submitted_qc>June 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Epidural analgesia</keyword>
  <keyword>Pneumonectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

